These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18849185)

  • 1. SPARC in cancer biology: its role in cancer progression and potential for therapy.
    Tai IT; Tang MJ
    Drug Resist Updat; 2008 Dec; 11(6):231-46. PubMed ID: 18849185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host.
    Podhajcer OL; Benedetti L; Girotti MR; Prada F; Salvatierra E; Llera AS
    Cancer Metastasis Rev; 2008 Sep; 27(3):523-37. PubMed ID: 18459035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prototypic matricellular protein in the tumor microenvironment--where there's SPARC, there's fire.
    Clark CJ; Sage EH
    J Cell Biochem; 2008 Jun; 104(3):721-32. PubMed ID: 18253934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host.
    Podhajcer OL; Benedetti LG; Girotti MR; Prada F; Salvatierra E; Llera AS
    Cancer Metastasis Rev; 2008 Dec; 27(4):691-705. PubMed ID: 18542844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
    Puolakkainen PA; Brekken RA; Muneer S; Sage EH
    Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPARC and tumor growth: where the seed meets the soil?
    Framson PE; Sage EH
    J Cell Biochem; 2004 Jul; 92(4):679-90. PubMed ID: 15211566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis.
    Sangaletti S; Di Carlo E; Gariboldi S; Miotti S; Cappetti B; Parenza M; Rumio C; Brekken RA; Chiodoni C; Colombo MP
    Cancer Res; 2008 Nov; 68(21):9050-9. PubMed ID: 18974151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hevin/SC1, a matricellular glycoprotein and potential tumor-suppressor of the SPARC/BM-40/Osteonectin family.
    Sullivan MM; Sage EH
    Int J Biochem Cell Biol; 2004 Jun; 36(6):991-6. PubMed ID: 15094114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell metabolism: cancer's Achilles' heel.
    Kroemer G; Pouyssegur J
    Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological functions of maspin.
    Bailey CM; Khalkhali-Ellis Z; Seftor EA; Hendrix MJ
    J Cell Physiol; 2006 Dec; 209(3):617-24. PubMed ID: 17001697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting AAC-11 in cancer therapy.
    Faye A; Poyet JL
    Expert Opin Ther Targets; 2010 Jan; 14(1):57-65. PubMed ID: 20001210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of KLF6 and its splice variants in cancer therapy.
    DiFeo A; Martignetti JA; Narla G
    Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins, stem cells, and cancer.
    Gauthaman K; Fong CY; Bongso A
    J Cell Biochem; 2009 Apr; 106(6):975-83. PubMed ID: 19224538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of SPARC--matricellular protein in pathophysiology and tissue injury healing. Implications for gastritis and gastric ulcers.
    Phan E; Ahluwalia A; Tarnawski AS
    Med Sci Monit; 2007 Feb; 13(2):RA25-30. PubMed ID: 17261993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer.
    Wong SY; Crowley D; Bronson RT; Hynes RO
    Clin Exp Metastasis; 2008; 25(2):109-18. PubMed ID: 18058030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SPARC and malignant neoplasms].
    Cui Y; Wang TY
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):642-4. PubMed ID: 15949367
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular targeting as a new strategy for cancer chemotherapy].
    Nakano S
    Fukuoka Igaku Zasshi; 2000 Jan; 91(1):1-7. PubMed ID: 10714011
    [No Abstract]   [Full Text] [Related]  

  • 20. TRAIL as a target in anti-cancer therapy.
    Wu GS
    Cancer Lett; 2009 Nov; 285(1):1-5. PubMed ID: 19299078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.